Skip to content
Back to Guavy Wire
Stocks

Canadians Fall Short on Preventing Respiratory Illness

Instruments
MRK
Share

A recent study by Ipsos on behalf of Merck Canada has revealed that while Canadians prioritize protecting vulnerable individuals and family members from respiratory illness, many may be missing opportunities to take proactive steps ahead of the upcoming respiratory illness season.

The survey found that nearly half (48%) of Canadians reported receiving none of the surveyed respiratory vaccines for influenza, COVID-19, RSV or pneumococcal disease in the last 12 months. Awareness of lesser-known respiratory illnesses like RSV and pneumococcal disease was also lower among respondents.

The survey highlighted a gap between awareness and prevention, with only about one-third (36%) of Canadians saying they are likely to proactively discuss respiratory illness prevention with a healthcare professional in the coming months. Family physicians, government health websites, and pharmacists were identified as trusted sources of information on respiratory illnesses and vaccines.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc